LONG-TERM TREATMENT OF TYPE-III HYPERLIPOPROTEINEMIA WITH CLOFIBRATE

被引：13
|
作者：
STUYT, PMJ [1 ]
DEMACKER, PNM [1 ]
VANTLAAR, A [1 ]
机构：
[1] CATHOLIC UNIV NIJMEGEN, DEPT MED, NIJMEGEN, NETHERLANDS
来源：
ATHEROSCLEROSIS | 1981年 / 40卷 / 3-4期
关键词：
D O I：
10.1016/0021-9150(81)90143-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：329 / 336
页数：8
相关论文
共 50 条
  • [1] COMPARATIVE EFFECTS OF GEMFIBROZIL AND CLOFIBRATE IN TYPE-III HYPERLIPOPROTEINEMIA
    LARSEN, ML
    ILLINGWORTH, DR
    OMALLEY, JP
    ATHEROSCLEROSIS, 1994, 106 (02) : 235 - 240
  • [2] HYPOLIPIDEMIC EFFECTS OF LOVASTATIN AND CLOFIBRATE IN TYPE-III HYPERLIPOPROTEINEMIA
    ILLINGWORTH, DR
    OMALLEY, JP
    ARTERIOSCLEROSIS, 1989, 9 (05): : A741 - A741
  • [3] TYPE-III HYPERLIPOPROTEINEMIA - STUDY OF THE PATHOGENESIS AND THE EFFECT OF CLOFIBRATE
    STUYT, PMJ
    DEMACKER, PNM
    STALENHOEF, AFH
    SCHADE, RWB
    LUTTERMAN, JA
    VANTLAAR, A
    NETHERLANDS JOURNAL OF MEDICINE, 1979, 22 (05): : 171 - 172
  • [4] TYPE-III HYPERLIPOPROTEINEMIA - THE TURNOVER RATE OF PLASMA TRIGLYCERIDES AND THE RESPONSE TO CLOFIBRATE
    STUYT, PMJ
    DEMACKER, PNM
    STALENHOEF, AFH
    SCHADE, RWB
    LUTTERMAN, JA
    VANTLAAR, A
    NETHERLANDS JOURNAL OF MEDICINE, 1982, 25 (08): : 245 - 254
  • [5] TYPE-III HYPERLIPOPROTEINEMIA
    不详
    LANCET, 1975, 1 (7914): : 1021 - 1022
  • [6] THE HYPOLIPIDEMIC EFFECTS OF LOVASTATIN AND CLOFIBRATE ALONE AND IN COMBINATION IN PATIENTS WITH TYPE-III HYPERLIPOPROTEINEMIA
    ILLINGWORTH, DR
    OMALLEY, JP
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (04): : 403 - 409
  • [7] EFFECT OF FENOFIBRATE TREATMENT ON TYPE-III HYPERLIPOPROTEINEMIA
    FRUCHART, JC
    DAVIGNON, J
    BARD, JM
    GROTHE, AM
    RICHARD, A
    FIEVET, C
    AMERICAN JOURNAL OF MEDICINE, 1987, 83 (5B): : 71 - 74
  • [8] A COMPARATIVE-STUDY OF THE EFFECTS OF ACIPIMOX AND CLOFIBRATE IN TYPE-III AND TYPE-IV HYPERLIPOPROTEINEMIA
    STUYT, PMJ
    STALENHOEF, AFH
    DEMACKER, PNM
    VANTLAAR, A
    ATHEROSCLEROSIS, 1985, 55 (01) : 51 - 62
  • [9] LONG-TERM THERAPY OF HYPERLIPOPROTEINEMIA (TYPE IIA, IIB, III, AND IV) WITH CLOFIBRATE IN RESPECT TO TOLERANCE AND SIDE-EFFECTS
    SCHWARTZKOPFF, W
    HOFFMANN, H
    RUSS, E
    HERZ KREISLAUF, 1973, 5 (11): : 474 - 482
  • [10] DIAGNOSIS OF TYPE-III HYPERLIPOPROTEINEMIA
    MERTZ, DP
    KLINISCHE WOCHENSCHRIFT, 1983, 61 (16): : 822 - 822
12345